The IBN SINA Pharmaceutical Industry PLC (DSE:IBNSINA)
Bangladesh · Delayed Price · Currency is BDT 322.40
+1.30 (0.40%)
At close: Aug 13, 2026
DSE:IBNSINA Market Cap
DSE:IBNSINA has a market cap or net worth of 10.07 billion as of August 14, 2026. Its market cap has increased by 5.02% in one year.
Market Cap
10.07B
Enterprise Value
13.36B
Revenue
13.48B
Ranking
n/a
PE Ratio
12.78
Stock Price
322.40
ChartMarket Cap Chart
Since May 3, 2012, DSE:IBNSINA's market cap has increased from 1.73B to 10.07B, an increase of 482.20%. That is a compound annual growth rate of 13.12%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2026 | 10.07B | 2.68% |
| Dec 30, 2025 | 9.81B | 9.48% |
| Dec 30, 2024 | 8.96B | 0.07% |
| Dec 28, 2023 | 8.95B | - |
| Dec 29, 2022 | 8.95B | 5.64% |
| Dec 30, 2021 | 8.48B | 11.19% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Unilever Consumer Care | 39.32B |
| Beacon Pharmaceuticals | 24.76B |
| The ACME Laboratories | 17.61B |
| Asiatic Laboratories | 14.34B |
| Navana Pharmaceuticals | 7.45B |
| Orion Pharma | 6.69B |
| Techno Drugs | 5.97B |
| Indo-Bangla Pharmaceuticals | 2.25B |